Actively Recruiting
Monogenic Diabetes Misdiagnosed as Type 1
Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2024-12-10
5000
Participants Needed
1
Research Sites
327 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study has two aims: 1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case selection. 2. To discover novel genes whose mutations cause monogenic diabetes misdiagnosed as T1D.
CONDITIONS
Official Title
Monogenic Diabetes Misdiagnosed as Type 1
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type.
You will not qualify if you...
- Existing type 1 diabetes autoantibody testing with a positive result
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Montreal Children's Hospital
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
Research Team
C
Constantin Polychronakos, MD
CONTACT
A
Angeliki Makri, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here